Beijing Earlybird Industry Development Co., Ltd.

[Beijing China (Mainland) ]

  • 18th
Business Type:
Manufacturer
Year Established:
0
Total Revenue:
Main Markets:
North America, South America, Eastern Europe, Mid East, Eastern Asia, Western Europe

Company Description

Beijing Earlybird Industry Development Co.,Ltd is a fast developing company, focus on the R&D, manufacture and exporting of APIs (Emphasize particularly on Oncology, Nucleotide, Immunology, Cardiovascular, Neurology etc) and associated pharmaceutical intermediates.

Paclitaxel, Docetaxel, Oxaliplatin, Lapatinib, Fulvestrant, Doxorubicin, 5-Fluorouracil, Entecavir, Adefovir, Adefovir Dipivoxil, Tenofovir, Tenofovir Disoproxil Fumarate, Lamivudine, Emtritabine, Pravastatin, Simvastatin, Coenzyme Q10, Meropenem, Tramadol Hydrochloride, Tamsulosin Hydrochloride, Dutasteride, Rocuronium Bromide and so on, totaled more than ten kinds APIs are our main products. There are also some APIs and Intermediates which are custom-tailored and synthesized according to the customer's requirements.

BEIJING Earlybird attaches much importance to the product's quality and excellence. Such as Entecavir's  research & produce & provide, we have achieved the advanced technology in CHINA.

In additional, BEIJING Earlybird co-operate with some big research institutes and manufactories in CHINA to jointly research, produce and sell some other APIs, Intermediates, Food Additives and Herbal Extracts.

All of our products available information, you can further learned from our products catalogue.

The business of BEIJING Earlybird, not only emphasizing the domestic market, but also paying more attention to the international market. Welcome all home and abroad manufactories, trading companies and research institutes and experts to contact with us and establish mutualism business relationships.